Basilea will seek approval of ceftobiprole for SAB as well as acute bacterial skin and skin structure infection ... by methicillin-resistant strains (MRSA), said Basilea. Ceftobiprole was turned ...

Learn how the introduction of a health promotion role increased onward referrals to smoking cessation and live lighter ...

Dalbavancin is under clinical development by AbbVie and currently in Phase III for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. According to GlobalData, Phase III drugs for ...

SYG-180-7 is similar to SYG-180-2-2 in structure and has strong hydrophobicity. The purpose of this study was to investigate the effect of SYG-180-2-2 at a subinhibitory concentration (4 μg/ml) on the ...

When you first enter a new world, you can either spawn near a structure or find one while exploring any of the three dimensions. While finding some can be quite easy, others are extremely hard to ...

The important point for patients is how many effective drugs remain. The public understands correctly that MRSA, flesh-eating bacteria, and other potentially deadly bacteria deserve attention and ...

For Cresemba, this comprises a milestone payment for sales in Canada, by AVIR Pharma Inc, as well as the first sales milestone payment for the Middle East and North Africa (MENA) region, by Hikma ...

Millions of children in Africa rely on funding from the United States for HIV care or testing — support that was threatened last month when President Donald J. Trump froze foreign aid spending ...

They have, however, been evaluated for efficacy in mild uncomplicated skin and skin structure infection (uSSSI), including impetigo, SIDs and secondarily infected wounds. Topical antibiotics are ...

I find that predictable, but apparently insurance companies don’t. My home is an entirely concrete structure with a dirt-over-concrete roof. Recently our insurance was canceled because we are in ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...